1,401 results on '"Leemans, C. René"'
Search Results
202. Multiparametric functional MRI and 18F-FDG-PET for survival prediction in patients with head and neck squamous cell carcinoma treated with (chemo)radiation
203. Evaluation of the modified Pittsburgh classification for predicting the disease‐free survival outcome of squamous cell carcinoma of the external auditory canal
204. Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic
205. Elective Neck Dissection or Sentinel Lymph Node Biopsy in Early Stage Oral Cavity Cancer Patients: The Dutch Experience
206. Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
207. Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy
208. A systematic review on Transoral robotic surgery (TORS) for carcinoma of unknown primary origin: Has tongue base mucosectomy become indispensable?
209. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy
210. Ovarian cancer‐derived copy number alterations signatures are prognostic in chemoradiotherapy‐treated head and neck squamous cell carcinoma
211. Development and Validation of a Novel and Rapid Molecular Detection Method for High-Risk Human Papillomavirus in Formalin-Fixed, Paraffin-Embedded Tumor Tissue
212. Management of Multiple Secreting Paragangliomas in a Succinate Dehydrogenase Subunit D (SDHD) Variant Carrier
213. Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation
214. Molecular Characterization of Locally Relapsed Head and Neck Cancer after Concomitant Chemoradiotherapy
215. Optimizing Survival Predictions of Hypopharynx Cancer: Development of a Clinical Prediction Model
216. Drug Sensitivity Prediction Models Reveal a Link between DNA Repair Defects and Poor Prognosis in HNSCC
217. Organ Preservation and Late Functional Outcome in Oropharyngeal Carcinoma: Rationale of EORTC 1420, the “Best of” Trial
218. Fifteen-year history of the European head and neck society
219. Prevalence of sleep disturbances among head and neck cancer patients: A systematic review and meta-analysis
220. Re-irradiation of a second localization of idiopathic midline destructive disease in the head and neck area
221. Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus–Positive Oropharyngeal Carcinoma.
222. A structured expressive writing activity targeting body image-related distress among head and neck cancer survivors: who do we reach and what are the effects?
223. Clinical and Molecular Characteristics of Squamous Cell Carcinomas From Fanconi Anemia Patients
224. Prevalence and clinical and psychological correlates of high fear of cancer recurrence in patients newly diagnosed with head and neck cancer
225. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV) : an open-label randomised controlled phase 3 trial
226. Genetic Patterns in Head and Neck Cancers That Contain or Lack Transcriptionally Active Human Papillomavirus
227. A genetic progression model of oral cancer: current evidence and clinical implications
228. The course of health-related quality of life from diagnosis to two years follow-up in patients with oropharyngeal cancer: does HPV status matter?
229. The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma.
230. Assessment and Clinical Significance of Micrometastases in Lymph Nodes of Head and Neck Cancer Patients Detected by E48 (Ly-6D) Quantitative Reverse Transcription-Polymerase Chain Reaction
231. Preface
232. Erratum to: The molecular landscape of head and neck cancer (Nature Reviews Cancer, (2018), 18, 5, (269-282), 10.1038/nrc.2018.11)
233. High rate of unexpected lymphatic drainage patterns and a high accuracy of the sentinel lymph node biopsy in oral cancer after previous neck treatment
234. Biochemically silent sympathetic Paraganglioma, Pheochromocytoma or Metastatic Disease in SDHD mutation carriers
235. Factors associated with depression over time in head and neck cancer patients: A systematic review
236. Acute Hypoxia Profile is a Stronger Prognostic Factor than Chronic Hypoxia in Advanced Stage Head and Neck Cancer Patients
237. Health-related and cancer-related Internet use by patients treated with total laryngectomy
238. Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)
239. Quality assurance in head and neck cancer surgery: where are we, and where are we going?
240. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy
241. Stepped care targeting psychological distress in head and neck cancer and lung cancer patients: which groups specifically benefit? Secondary analyses of a randomized controlled trial
242. Assessment of Neurocognitive Impairment and Speech Functioning Before Head and Neck Cancer Treatment
243. Depth of invasion in patients with early stage oral cancer staged by sentinel node biopsy
244. Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining
245. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
246. Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review
247. Risk groups for survival in HPV-positive and HPV-negative OPSCC
248. Management of recurrent ameloblastoma of the jaws; a 40-year single institution experience
249. Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck
250. Multiparametric functional MRI and 18F-FDG-PET for survival prediction in patients with head and neck squamous cell carcinoma treated with (chemo)radiation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.